1 – 20 of 28
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Prevalence and factors associated with faecal carriage of extended-spectrum β-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia
(
- Contribution to journal › Article
- 2021
-
Mark
HIV drug resistance among adults initiating antiretroviral therapy in Uganda
(
- Contribution to journal › Article
- 2020
-
Mark
Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
(
- Contribution to journal › Article
- 2019
-
Mark
Defining optimal dosing of ciprofloxacin in patients with septic shock
(
- Contribution to journal › Article
- 2016
-
Mark
NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection.
(
- Contribution to journal › Article
-
Mark
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
(
- Contribution to journal › Article
- 2014
-
Mark
Group A streptococci are protected from amoxicillin-mediated killing by vesicles containing β-lactamase derived from Haemophilus influenzae.
(
- Contribution to journal › Article
-
Mark
Prevalence, distribution and transfer of small β-lactamase-containing plasmids in Swedish Haemophilus influenzae.
(
- Contribution to journal › Article
- 2013
-
Mark
Outer membrane vesicles shield Moraxella catarrhalis β-lactamase from neutralization by serum IgG.
(
- Contribution to journal › Article
- 2012
-
Mark
The epithelium-produced growth factor midkine has fungicidal properties.
(
- Contribution to journal › Article
-
Mark
Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
(
- Contribution to journal › Article
- 2010
-
Mark
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
(
- Contribution to journal › Article
- 2007
-
Mark
Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner
(
- Contribution to journal › Article
- 2006
-
Mark
Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation
(
- Contribution to journal › Article
-
Mark
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
(
- Contribution to journal › Article
-
Mark
Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids
(
- Contribution to journal › Article
- 2005
-
Mark
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry
(
- Contribution to journal › Article
- 2004
-
Mark
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.
(
- Contribution to journal › Article
-
Mark
A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
(
- Contribution to journal › Article